Unknown

Dataset Information

0

Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients


ABSTRACT: Synopsis We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15-8% of in hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.

SUBMITTER: Tarantino N 

PROVIDER: S-EPMC8554003 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8014654 | biostudies-literature
| S-EPMC7668347 | biostudies-literature
| S-EPMC9194914 | biostudies-literature
| S-EPMC8976231 | biostudies-literature
| S-EPMC8710627 | biostudies-literature
| S-EPMC8710622 | biostudies-literature
| S-EPMC9542611 | biostudies-literature
| S-EPMC10033174 | biostudies-literature
2021-06-18 | GSE178404 | GEO
2022-08-03 | GSE210223 | GEO